Clive, IANCT05751668Now EnrollingIRB Ready

Neuropathy Clinical Trial in Clive, IA

Access cutting-edge neuropathy treatment through this clinical trial at a research site in Clive. Study-provided care at no cost to qualified participants.

Sponsored by Alliance for Clinical Trials in Oncology

Quick Self-Assessment

See if you qualify for this Clive location

Preparing your pre-screening questions...

Expert Care in Clive

Access neuropathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related neuropathy treatment provided free

Apply for This Clive Location

Check if you qualify for this neuropathy clinical trial in Clive, IA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Clive

    Convenient for IA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Clive site if eligible
  4. 4Begin participation

About This Neuropathy Study in Clive

This phase II trial tests the safety, side effects, and best dose of monosialotetrahexosylganglioside (GM1) and whether it works in reducing or preventing chemotherapy-induced peripheral neuropathy (CIPN) in patients with breast cancer that has spread from where it first started (primary site) to other places in the body (metastatic) who are receiving treatment with paclitaxel. Chemotherapy drugs, such as paclitaxel, work in different ways to stop the growth of cancer cells, either by killing th

Sponsor: Alliance for Clinical Trials in Oncology

Who Can Participate

Inclusion Criteria

Documentation of disease: Histologic diagnosis of metastatic breast cancer in women or men
Prior treatment- No previous exposure to GM1
Planned administration of paclitaxel, either given weekly, or weekly 3 weeks on/1 week off, to patients with metastatic cancer at a dose of 80 mg/m\^2
No planned treatment with concurrent immunotherapy
Score of 1 (none) and/or 2 (a little) on the six individual European Organization for Research and Treatment of Cancer (EORTC) Quality of Life questionnaire (QLQ)- chemotherapy-induced peripheral neuropathy (CIPN)20 questions that quantify numbness (N), tingling (T), and pain in the fingers/hands and toes/feet (Items #31-36)
No diagnosis of fibromyalgia
No history of significant respiratory tract infection and/or infectious diarrhea within 14 days before registration
No history of stroke or cerebrovascular accident in the past 6 months prior to registration
No history of diagnosed neurologic or psychiatric disorders

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Clive?

Yes, this clinical trial (NCT05751668) has an active research site in Clive, IA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Neuropathy Treatment Options in Clive, IA

If you're searching for neuropathy treatment options in Clive, IA, this clinical trial (NCT05751668) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Clive research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all neuropathy clinical trials near you to find additional studies recruiting in your area.

More Neuropathy Trials in Clive, IA

See all neuropathy clinical trials recruiting in Clive — not just this study.

Browse Neuropathy Trials in Clive

Ready to Join in Clive?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Clive, IA